Related Experiment Videos
Recombination activating gene and its defects
A Villa1, C Sobacchi, P Vezzoni
1Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Segrate, Italy. villa@itba.mi.cnr.it
Current Opinion in Allergy and Clinical Immunology
|April 20, 2002
Abstract:
Mutations in recombination activating genes cause a spectrum of severe immunodeficiencies ranging from T-B severe combined immunodeficiency to Omenn syndrome (a particular type of severe combined immunodeficiency presenting a T+ B- profile). Although environmental factors and genetic background could also contribute to the genesis of this pathological condition, a residual recombination activating gene activity allowing for a few recombinational events to occur, is the first determinant of this variability in the clinical picture.